Randomized, Prospective, Double Blind, Multi-Center, Phase 3 Pivotal Clinical Trial to Compare Efficacy and Safety of CARTISTEM® and Surgical Comparator in Subjects With Knee Cartilage Lesions and Osteoarthritis
Medipost, Inc.
Summary
This study will test whether CARTISTEM is safe and works better than debridement (a surgery that cleans out damaged tissue) for people with knee cartilage damage and osteoarthritis. CARTISTEM is a new treatment made of stem cells from donated umbilical cord blood mixed with a gel (hyaluronic acid) that is placed in the damaged area of the knee The main goal is to find out if CARTISTEM® reduces knee pain and improves knee function more than debridement two years after treatment. The study will also use MRI scans to explore whether CARTISTEM® may slow the worsening of osteoarthritis over time.
Description
To establish the efficacy and safety of CARTISTEM®, a combination product composed of allogeneic human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) formulated with a cross-linked sodium hyaluronate (HA) hydrogel, CARTISTEM® compared to the surgical comparator of debridement in Subjects with knee cartilage lesions and osteoarthritis. This trial is intended to provide evidence of the superiority of CARTISTEM® to reduce knee pain and improve knee function compared to debridement for Subjects with knee cartilage lesions and osteoarthritis at 2-years post-treatment. Additionall…
Eligibility
- Age range
- 18–75 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: 1. Age ≥ 18 and ≤ 75 years old. 2. Knee Osteoarthritis diagnosed in the index knee according to the clinical definition of American College of Rheumatology (ACR) guidelines at screening. 3. Failed conservative knee osteoarthritis treatment for at least 3 months prior to consent (weight reduction, physical therapy, injections, pain medications, etc.). 4. Kellgren-Lawrence (KL) in the index knee of grade 2 to 3 as determined by independent radiologist review of study X-Ray. 5. Clinically relevant femoral cartilage defects classified using modified Outerbridge Grade 3 or 4 in…
Interventions
- BiologicalCARTISTEM® + Debridement
CARTISTEM group: CARTISTEM is made of two parts supplied in separate vials: (1) about 7.5 million stem cells from human umbilical cord blood (hUCB-MSCs ) suspended in 1.5 ml of liquid medium, and (2) 60 mg of sodium hyaluronate, a gel-forming substance, supplied as a freeze-dried powder. The two parts are mixed together to form a thick, moldable gel that is placed in the damaged area of the knee. During surgery small holes are made into the bone where the arthritis exists to stimulate the patient's bone marrow, so the stem cells can interact and re-grow the missing cartilage. Is important to note that the stem cells do not cause an immune response and the patient will grow their own cartilage.
- ProcedureDebridement
Debridement is a standard surgical procedure for knee cartilage damage. It is done arthroscopically (through small incisions with a camera and instruments) or through a small open incision. The surgeon removes damaged cartilage and unstable tissue from the knee and smooths the edges.
Locations (37)
- Flourish Research BirminghamBirmingham, Alabama
- Scottsdale Clinical Trials, LLC - Elite Clinical NetworkScottsdale, Arizona
- AZ OrthopedicTempe, Arizona
- TriWest Research AssociatesEl Cajon, California
- CORE Orthopaedic Medical CenterEncinitas, California
- Horizon Clinical Research - La JollaLa Jolla, California